# Project III - Comprehensive Genomic Evaluation of Structural Birth Defects

> **NIH NIH P01** · SEATTLE CHILDREN'S HOSPITAL · 2024 · $385,897

## Abstract

PROJECT SUMMARY
Structural birth defects (SBD) affect 3-6% of live births and are a leading cause of infant morbidity and mortality
worldwide. Most SBD are isolated, occur in the first 10 weeks of human development, and are thought to be
driven by genetic, epigenetic, and environmental factors.
Technical advances in DNA sequencing have propelled our understanding of the genetics of SBD. Array based
technologies identified copy number variants that contribute to SBD and enabled genome wide association
studies. Massively parallel “Next Generation” (NGS) methods sequence large numbers of short (50-300 base
pairs) pieces of DNA simultaneously, permitting sequencing of all coding regions (the exome) or the entire
genome at once. Exome and genome sequencing of blood-derived DNA identifies the molecular etiology of
~50% of children multisystemic, syndromic SBD. However, the etiology of most SBD- both isolated and
syndromic- remains unknown.
A potential reason for this is that short-read based sequencing of blood-derived DNA does not provide a
comprehensive view of an individual’s genome.
The goal of this proposal is to use novel technologies in prospective cohorts of children with SBD to identify
genetic variation not identified by current methods. These “hidden” variants include duplications, inversions,
repeat expansions/contractions, and epigenetic modifications that standard short-read based methods cannot
identify (Aim 1). Hidden variants also include DNA mutations that arise post-zygotically (“mosaic”) and are not
present in blood-derived DNA (Aim 2).
We will use long-read based DNA and RNA sequencing methods (PacBio and Oxford Nanopore) on patients
with syndromic SBD whose clinical workup (including exome sequencing) has been non-diagnostic. In patients
with isolated SBD whose clinical workup has been non-diagnostic, we will apply deep short-read based DNA
sequencing of multiple, non-blood derived tissues to identify mosaic variants.
This proposal aligns with the stated goals of the NICHD, as our findings will form the basis of new strategies for
the diagnosis, treatment, and prevention of human structural birth defects. Our work furthers that goal by
identifying previously undetected genetic variation in children with SBD. This is a key first step towards
establishing a framework for utilizing these novel technologies in the clinical diagnostic arena.

## Key facts

- **NIH application ID:** 10756450
- **Project number:** 5P01HD104435-04
- **Recipient organization:** SEATTLE CHILDREN'S HOSPITAL
- **Principal Investigator:** Katrina M Dipple
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $385,897
- **Award type:** 5
- **Project period:** 2021-01-11 → 2025-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10756450

## Citation

> US National Institutes of Health, RePORTER application 10756450, Project III - Comprehensive Genomic Evaluation of Structural Birth Defects (5P01HD104435-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10756450. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*